Michael S. Ritsner, MD, PhD
- 3Articles
- 41KReads
- 2010–2013Active
- 15Collaborators
- 196Citations
About
Michael S. Ritsner, MD, PhD, has published research on the treatment of schizophrenia and schizoaffective disorders. His work includes clinical trials investigating pharmacological interventions such as the retinoid X receptor agonist bexarotene, L-theanine, and neurosteroids pregnenolone and dehydroepiandrosterone as adjunctive therapies. His studies, conducted between 2010 and 2013, focus on symptom relief in these psychiatric conditions.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
